These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 32950593)
1. Nanozyme-mediated cascade reaction based on metal-organic framework for synergetic chemo-photodynamic tumor therapy. Sheng S; Liu F; Lin L; Yan N; Wang Y; Xu C; Tian H; Chen X J Control Release; 2020 Dec; 328():631-639. PubMed ID: 32950593 [TBL] [Abstract][Full Text] [Related]
2. Manganese-Based Nanoplatform As Metal Ion-Enhanced ROS Generator for Combined Chemodynamic/Photodynamic Therapy. Wang P; Liang C; Zhu J; Yang N; Jiao A; Wang W; Song X; Dong X ACS Appl Mater Interfaces; 2019 Nov; 11(44):41140-41147. PubMed ID: 31603650 [TBL] [Abstract][Full Text] [Related]
3. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy. Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242 [TBL] [Abstract][Full Text] [Related]
4. A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects. An G; Zheng H; Guo L; Huang J; Yang C; Bai Z; Wang N; Yang W; Zhu Y J Colloid Interface Sci; 2024 May; 662():298-312. PubMed ID: 38354557 [TBL] [Abstract][Full Text] [Related]
5. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress. Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803 [TBL] [Abstract][Full Text] [Related]
6. A Mesoporous Nanoenzyme Derived from Metal-Organic Frameworks with Endogenous Oxygen Generation to Alleviate Tumor Hypoxia for Significantly Enhanced Photodynamic Therapy. Wang D; Wu H; Lim WQ; Phua SZF; Xu P; Chen Q; Guo Z; Zhao Y Adv Mater; 2019 Jul; 31(27):e1901893. PubMed ID: 31095804 [TBL] [Abstract][Full Text] [Related]
7. Metal-Organic Frameworks with Enhanced Photodynamic Therapy: Synthesis, Erythrocyte Membrane Camouflage, and Aptamer-Targeted Aggregation. Zhao Y; Wang J; Cai X; Ding P; Lv H; Pei R ACS Appl Mater Interfaces; 2020 May; 12(21):23697-23706. PubMed ID: 32362109 [TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded pH-responsive nanoparticles coated with chlorin e6 for drug delivery and synergetic chemo-photodynamic therapy. Liang J; Jin X; Chen B; Hu J; Huang Q; Wan J; Hu Z; Wang B Nanotechnology; 2020 May; 31(19):195103. PubMed ID: 31978912 [TBL] [Abstract][Full Text] [Related]
9. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy. Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633 [TBL] [Abstract][Full Text] [Related]
10. Construction of PEGylated chlorin e6@CuS-Pt theranostic nanoplatforms for nanozymes-enhanced photodynamic-photothermal therapy. Sheng Y; Ren Q; Tao C; Wen M; Qu P; Yu N; Li M; Chen Z; Xie X J Colloid Interface Sci; 2023 Sep; 645():122-132. PubMed ID: 37146376 [TBL] [Abstract][Full Text] [Related]
11. MOF-coated upconversion nanoconstructs for synergetic photo-chemodynamic/oxygen-elevated photodynamic therapy. Chu H; Li Y; Wang C; Shen JW; Wei Y Dalton Trans; 2022 Nov; 51(42):16336-16343. PubMed ID: 36226500 [TBL] [Abstract][Full Text] [Related]
12. Mitochondria-Targeting Upconversion Nanoparticles@MOF for Multiple-Enhanced Photodynamic Therapy in Hypoxic Tumor. Chen Y; Yang Y; Du S; Ren J; Jiang H; Zhang L; Zhu J ACS Appl Mater Interfaces; 2023 Aug; 15(30):35884-35894. PubMed ID: 37487181 [TBL] [Abstract][Full Text] [Related]
13. Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor. Wang D; Wu H; Phua SZF; Yang G; Qi Lim W; Gu L; Qian C; Wang H; Guo Z; Chen H; Zhao Y Nat Commun; 2020 Jan; 11(1):357. PubMed ID: 31953423 [TBL] [Abstract][Full Text] [Related]
14. Photo-triggered self-destructive ROS-responsive nanoparticles of high paclitaxel/chlorin e6 co-loading capacity for synergetic chemo-photodynamic therapy. Yang X; Shi X; Zhang Y; Xu J; Ji J; Ye L; Yi F; Zhai G J Control Release; 2020 Jul; 323():333-349. PubMed ID: 32325174 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy. Feng L; Chen M; Li R; Zhou L; Wang C; Ye P; Hu X; Yang J; Sun Y; Zhu Z; Fang K; Chai K; Shi S; Dong C Acta Biomater; 2022 Jan; 138():463-477. PubMed ID: 34718179 [TBL] [Abstract][Full Text] [Related]
16. O Sun Q; Bi H; Wang Z; Li C; Wang C; Xu J; Yang D; He F; Gai S; Yang P ACS Appl Mater Interfaces; 2019 Oct; 11(40):36347-36358. PubMed ID: 31525886 [TBL] [Abstract][Full Text] [Related]
17. Metal-Organic Framework PCN-224 Combined Cobalt Oxide Nanoparticles for Hypoxia Relief and Synergistic Photodynamic/Chemodynamic Therapy. Yuan H; Chen K; Geng J; Wu Z; Wang C; Shi P Chemistry; 2024 Jun; 30(36):e202400319. PubMed ID: 38606488 [TBL] [Abstract][Full Text] [Related]
18. MOF(Fe)-derived composites as a unique nanoplatform for chemo-photodynamic tumor therapy. Mo Z; Pan X; Pan X; Ye L; Hu H; Xu Q; Hu X; Xu Z; Xiong J; Liao G; Yang S J Mater Chem B; 2022 Nov; 10(42):8760-8770. PubMed ID: 36255232 [TBL] [Abstract][Full Text] [Related]
19. Cancer-Responsive Multifunctional Nanoplatform Based on Peptide Self-Assembly for Highly Efficient Combined Cancer Therapy by Alleviating Hypoxia and Improving the Immunosuppressive Microenvironment. Wu J; Liu Y; Cao M; Zheng N; Ma H; Ye X; Yang N; Liu Z; Liao W; Sun L ACS Appl Mater Interfaces; 2023 Feb; 15(4):5667-5678. PubMed ID: 36651290 [TBL] [Abstract][Full Text] [Related]
20. Peroxide-Simulating and GSH-Depleting Nanozyme for Enhanced Chemodynamic/Photodynamic Therapy via Induction of Multisource ROS. Liu G; Liu M; Li X; Ye X; Cao K; Liu Y; Yu Y ACS Appl Mater Interfaces; 2023 Oct; 15(41):47955-47968. PubMed ID: 37812458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]